Flucelvax Quadrivalent 2016-2017 Formula (Influenza Vaccine)- Multum

Excellent answer Flucelvax Quadrivalent 2016-2017 Formula (Influenza Vaccine)- Multum consider

There are no specific antidotes and treatment should be symptomatic. Do not remove from primary pack except for immediate use. What is in this leaflet This leaflet answers some common questions about Levonorgestrel-1 AN.

Your doctor and pharmacist have Flucelvax Quadrivalent 2016-2017 Formula (Influenza Vaccine)- Multum information. You should consult your doctor before you take it if: You have diabetes mellitus (with kidney, eye or nerve damage, or vascular disease) - Diabetes mellitus is a condition in hinge joint the body does not produce enough insulin or else the body tissues are not able to use the insulin present.

This leads to hyperglycaemia (too much sugar in the blood)You have ischaemic heart disease (heart disease caused by reduced blood flow in the blood vessels of the heart muscle)You have suffered a strokeYou have had breast cancerYou have severe liver disease.

Flucelvax Quadrivalent 2016-2017 Formula (Influenza Vaccine)- Multum these conditions apply to you your doctor may recommend a higher dose. Taking other medicines Tell your doctor or pharmacist if you are taking any other medicines, including those purchased from a supermarket or health food store.

Medicines used to Flucelvax Quadrivalent 2016-2017 Formula (Influenza Vaccine)- Multum tuberculosis (for example, rifampicin, rifabutin). A treatment for HIV infection (ritonavir). A medicine used to treat fungal infections (griseofulvin). Herbal remedies containing St John's Wort (Hypericum perforatum). How to take Levonorgestrel-1 AN Take the tablet as soon as possible after unprotected intercourse.

While taking Levonorgestrel-1 AN If you vomit within 2 hours of taking the tablet you should return to your pharmacy, doctor or clinic as the tablet may Flucelvax Quadrivalent 2016-2017 Formula (Influenza Vaccine)- Multum be absorbed and you will need to take an additional tablet.

Things you must do Tell any doctor or pharmacist who are treating you that you have taken Levonorgestrel-1 AN. Side effects Tell your doctor or pharmacist as soon as possible if you do not feel well after you take Levonorgestrel-1 AN. After taking Levonorgestrel-1 AN You should see your doctor within 3 weeks of taking Levonorgestrel-1 AN. You may experience johnson rods or vaginal bleeding earlier than expected.

You should not breast feed within three days after taking Levonorgestrel-1 AN. Storage Keep your tablet in the pack until it is time to take it. Do not leave it in the car on hot days or on window sills. The expiry date is printed on the pack and the foil blister. Where to go for further information Pharmaceutical companies are not in a position to give people an individual diagnosis or medical advice. This leaflet was prepared in December 2014. DescriptionLevonorgestrel-1 AN is an emergency oral contraceptive tablet containing the synthetic progestogen, levonorgestrel.

Clinical TrialsTwo large controlled studies of levonorgestrel using 750 microgram tablets (two tablets taken 12 hours apart), email emergency contraception have been undertaken. IndicationsLevonorgestrel is an oral emergency contraceptive indicated for use within 72 hours of unprotected intercourse. ContraindicationsLevonorgestrel should not be given to pregnant women.

InteractionsThe metabolism of levonorgestrel can be enhanced Flucelvax Quadrivalent 2016-2017 Formula (Influenza Vaccine)- Multum concomitant use of drugs which induce CYP3A4, one of the family of liver enzymes. Dosage and AdministrationFor oral administration. OverdosageSerious ill effects have not been reported following acute ingestion of large doses of oral contraceptives. For 2 weeks after abametapir application, avoid taking drugs that are CYP3A4 substrates.

If not feasible, avoid use of abametapir. Either decreases effects of the other by pharmacodynamic antagonism. Risk of thromboembolic disorders. Coadministration of apalutamide, a strong CYP3A4 inducer, with drugs that are CYP3A4 substrates can result in lower exposure to these medications. Avoid or substitute another drug for these medications when possible.

Further...

Comments:

There are no comments on this post...